EA201390016A1 - Способ получения производных пирано[2,3-c]пиридина - Google Patents
Способ получения производных пирано[2,3-c]пиридинаInfo
- Publication number
- EA201390016A1 EA201390016A1 EA201390016A EA201390016A EA201390016A1 EA 201390016 A1 EA201390016 A1 EA 201390016A1 EA 201390016 A EA201390016 A EA 201390016A EA 201390016 A EA201390016 A EA 201390016A EA 201390016 A1 EA201390016 A1 EA 201390016A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pirano
- pyridine
- derivatives
- producing
- formula
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Изобретение относится к способу, включающему стадию дегидратирования соединения формулы (I)подходящим дегидратирующим реагентом с образованием соединения формулы (II)где R-Rтакие, как определено в описании. Соединения формулы (II) являются перспективными в качестве промежуточных соединений для синтеза соединений, полезных для лечения бактериальных инфекций.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36588010P | 2010-07-20 | 2010-07-20 | |
PCT/US2011/044489 WO2012012391A2 (en) | 2010-07-20 | 2011-07-19 | Process for preparing pyrano - [2,3-c]pyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201390016A1 true EA201390016A1 (ru) | 2013-09-30 |
Family
ID=45497409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201390016A EA201390016A1 (ru) | 2010-07-20 | 2011-07-19 | Способ получения производных пирано[2,3-c]пиридина |
Country Status (10)
Country | Link |
---|---|
US (1) | US8759523B2 (ru) |
EP (1) | EP2595994B1 (ru) |
JP (1) | JP5762538B2 (ru) |
KR (1) | KR20130129902A (ru) |
CN (1) | CN103492393A (ru) |
BR (1) | BR112013001257A2 (ru) |
EA (1) | EA201390016A1 (ru) |
ES (1) | ES2574179T3 (ru) |
SG (1) | SG187146A1 (ru) |
WO (1) | WO2012012391A2 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA41169A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
CN105954913B (zh) | 2016-06-24 | 2021-02-26 | 京东方科技集团股份有限公司 | 一种液晶显示器及显示装置 |
CN112830933A (zh) * | 2021-02-04 | 2021-05-25 | 康化(上海)新药研发有限公司 | 一种3,4-二氢-2H-吡喃并[2,3-b]吡啶合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8613786D0 (en) | 1986-06-06 | 1986-07-09 | Beecham Group Plc | Active compounds |
DE10120619A1 (de) * | 2001-04-26 | 2002-10-31 | Merck Patent Gmbh | 2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman |
EP1442037A1 (en) * | 2001-11-09 | 2004-08-04 | PHARMACIA & UPJOHN COMPANY | Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands |
TW200427688A (en) * | 2002-12-18 | 2004-12-16 | Glaxo Group Ltd | Antibacterial agents |
-
2011
- 2011-07-19 CN CN201180035535.7A patent/CN103492393A/zh active Pending
- 2011-07-19 KR KR1020137003678A patent/KR20130129902A/ko not_active Application Discontinuation
- 2011-07-19 BR BR112013001257A patent/BR112013001257A2/pt not_active Application Discontinuation
- 2011-07-19 US US13/810,741 patent/US8759523B2/en active Active
- 2011-07-19 SG SG2013004452A patent/SG187146A1/en unknown
- 2011-07-19 EA EA201390016A patent/EA201390016A1/ru unknown
- 2011-07-19 ES ES11810260.7T patent/ES2574179T3/es active Active
- 2011-07-19 EP EP11810260.7A patent/EP2595994B1/en active Active
- 2011-07-19 JP JP2013520798A patent/JP5762538B2/ja active Active
- 2011-07-19 WO PCT/US2011/044489 patent/WO2012012391A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
SG187146A1 (en) | 2013-02-28 |
WO2012012391A3 (en) | 2013-08-08 |
EP2595994B1 (en) | 2016-04-20 |
BR112013001257A2 (pt) | 2016-05-17 |
WO2012012391A2 (en) | 2012-01-26 |
JP5762538B2 (ja) | 2015-08-12 |
JP2013541498A (ja) | 2013-11-14 |
US8759523B2 (en) | 2014-06-24 |
EP2595994A4 (en) | 2014-12-10 |
CN103492393A (zh) | 2014-01-01 |
ES2574179T3 (es) | 2016-06-15 |
KR20130129902A (ko) | 2013-11-29 |
EP2595994A2 (en) | 2013-05-29 |
US20130116436A1 (en) | 2013-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201391180A1 (ru) | Способ получения оптически активных производных дигидробензофурана | |
MY197904A (en) | Method for producing substituted 5-fluoro-1h-pyrazolopyridines | |
EA201201179A1 (ru) | Способ получения изоксазолиновых производных | |
EA201100666A1 (ru) | Тиоамидные соединения, способ их получения и способ их применения | |
JO2939B1 (en) | Tetrahydro-pyrido-pyrimidine derivatives | |
MX2009003257A (es) | Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina. | |
MX2013011257A (es) | Proceso para la preparacion de dronedarona por n-butilacion. | |
NZ586187A (en) | Processes for the synthesis of sinomenine derivatives and their intermediate | |
MX2009007436A (es) | Derivados espirociclicos de acido tetronico. | |
IN2014MN01521A (ru) | ||
EA201391554A1 (ru) | Способы получения макроциклических депсипептидов и новых промежуточных соединений | |
CY1111690T1 (el) | Μεθοδος για την παρασκευη δροσπιρενονης | |
IN2014DN00144A (ru) | ||
EA200801893A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления | |
EA201490998A1 (ru) | Способ получения сложных эфиров (5-фтор-2-метил-3-хинолин-2-илметил-индол-1-ил)-уксусной кислоты | |
MX355561B (es) | Proceso para hacer inhibidores de girasa y topoisomerasa iv. | |
EA201892052A1 (ru) | Способ получения органических соединений | |
EA201270237A1 (ru) | Способ получения 1-бензил-3-гидроксиметил-1н-индазола и его производных и необходимые промежуточные соединения, содержащие магний | |
EA201200820A1 (ru) | Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов | |
EA201390016A1 (ru) | Способ получения производных пирано[2,3-c]пиридина | |
WO2009121710A3 (en) | Process for preparing nebivolol | |
MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
EA201291235A1 (ru) | Новые способы | |
EA201300792A1 (ru) | Химические соединения | |
EA201590594A1 (ru) | Макролидные производные, их получение и их терапевтическое использование |